Suppr超能文献

异基因造血干细胞移植后血小板减少持续时间延长及其与核型减少和巨核细胞未成熟有关。

Prolonged thrombocytopenia following allogeneic hematopoietic stem cell transplantation and its association with a reduction in ploidy and an immaturation of megakaryocytes.

机构信息

Peking University People's Hospital, Peking University Institute of Hematology, Beijing, People's Republic of China.

出版信息

Biol Blood Marrow Transplant. 2011 Feb;17(2):274-80. doi: 10.1016/j.bbmt.2010.09.007. Epub 2010 Sep 18.

Abstract

Prolonged thrombocytopenia is a frequent complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT); however, its pathogenesis has remained obscure. In the present study, we used flow cytometry to determine the frequency of bone marrow megakaryocytes (MKs) and MK ploidy distributions in allo-HSCT recipients with or without prolonged thrombocytopenia (n = 32 and 27, respectively) and healthy volunteers (n = 13). In addition, the expression of c-Mpl in MKs was measured. The results indicate that the proportions of MKs in marrow mononuclear cells or the percentages of CD110(+) MKs in total MKs did not significantly differ between the 3 groups; however, in a comparison of nonthrombocytopenic allo-HSCT recipients to healthy volunteers, the allo-HSCT patients who had prolonged thrombocytopenia exhibited significant shifts toward low ploidy cells (left shift), which were accompanied by a marked increase in ≤ 8N cells (P = .036 and P < .001, respectively) and significant decreases in 16N cells (P < .001 and P < .001, respectively) and ≥ 32N cells (P = .01 and P <.001, respectively). These results indicate that there were more immature MKs in allo-HSCT recipients who had prolonged thrombocytopenia, in comparison to nonthrombocytopenic allo-HSCT recipients and healthy volunteers. We conclude that prolonged thrombocytopenia and slow platelet engraftment after allo-HSCT may be related to a reduction in ploidy and an immaturation of MKs.

摘要

异基因造血干细胞移植(allo-HSCT)后血小板减少症是一种常见的并发症;然而,其发病机制仍不清楚。在本研究中,我们使用流式细胞术来确定有或没有血小板减少症的 allo-HSCT 受者(分别为 32 名和 27 名)和健康志愿者(n = 13)的骨髓巨核细胞(MK)的频率和 MK 倍体分布。此外,还测量了 MK 中 c-Mpl 的表达。结果表明,骨髓单核细胞中 MK 的比例或总 MK 中 CD110(+)MK 的百分比在 3 组之间无显著差异;然而,在非血小板减少性 allo-HSCT 受者与健康志愿者的比较中,血小板减少症持续时间较长的 allo-HSCT 患者表现出向低倍体细胞的显著左移(左移),同时伴有≤8N 细胞的显著增加(P =.036 和 P <.001)和 16N 细胞的显著减少(P <.001 和 P <.001)和≥32N 细胞(P =.01 和 P <.001)。这些结果表明,与非血小板减少性 allo-HSCT 受者和健康志愿者相比,血小板减少症持续时间较长的 allo-HSCT 受者中存在更多不成熟的 MK。我们得出结论,allo-HSCT 后血小板减少症和血小板植入缓慢可能与倍体减少和 MK 不成熟有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验